| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/07/2007 | WO2007099154A1 Crush-resistant oxycodone tablets intended for preventing accidental misuse and unlawful diversion |
| 09/07/2007 | WO2007099152A1 Crush-resistant tablets intended to prevent accidental misuse and unlawful diversion |
| 09/07/2007 | WO2007099145A1 G-csf liquid formulation |
| 09/07/2007 | WO2007098968A1 Triggered release of liposome contents |
| 09/07/2007 | WO2007098686A1 Andrographis extract formulations |
| 09/07/2007 | WO2007098618A1 Ring pessary in the uterus |
| 09/07/2007 | WO2007098612A1 Gastric acid resistant gelatin capsule composition and method for producing same |
| 09/07/2007 | WO2007098611A1 Compositions for treatment of cancer |
| 09/07/2007 | WO2007082978B1 Taxane pharmaceutical formulation, solid taxane composition, method for preparing the solid taxane composition, composition for solubilising said solid taxane composition and set of elements (kit) for the injectable taxane formulation |
| 09/07/2007 | WO2007073398A3 Compositions and methods for the sustained release of beta-alanine |
| 09/07/2007 | WO2007071721A3 Ginger extract for inhibiting human drug transporters |
| 09/07/2007 | WO2007071708A3 Ginger fraction for inhibiting human cyp enzymes |
| 09/07/2007 | WO2007068615A3 Hcv prodrug formulation |
| 09/07/2007 | WO2007066178A3 Capsules or microcapsules with stable outer hydrophilic layer for rapid buccal disintegration |
| 09/07/2007 | WO2007066149A3 Topical pharmaceutical compositions |
| 09/07/2007 | WO2007065638A3 Matrix-controlled transdermal system comprising salts of ace inhibitor dicarboxylic acids |
| 09/07/2007 | WO2007052125A3 Solid oral pharmaceutical compositions for once daily dosing containing pregabalin, a matrix forming agent and a swelling agent |
| 09/07/2007 | WO2007050543A3 Topical pharmaceutical foam composition |
| 09/07/2007 | WO2007045689A3 Inhalatory pharmaceutical compositions in form of dry powders, solutions or suspensions |
| 09/07/2007 | WO2007044976A3 Improved testosterone gel and method of use |
| 09/07/2007 | WO2007041272A3 Long lasting natural anti-pest additive |
| 09/07/2007 | WO2007030431A3 Gelatin capsules containing actives |
| 09/07/2007 | WO2007028978A3 Ramipril formulation |
| 09/07/2007 | WO2007025182A3 Drug compositions containing controlled release hypromellose matrices |
| 09/07/2007 | WO2007016450A3 Methods for treating or preventing reactivation of a latent herpesvirus infection |
| 09/07/2007 | WO2007009730A3 Polymer film for transdermal patches containing a pharmaceutical active agent |
| 09/07/2007 | WO2006131721A3 Topical ungual formulations |
| 09/07/2007 | WO2006122309B1 Stable lyophilized anthracycline glycosides |
| 09/07/2007 | WO2006102965A9 Multiparticulate pharmaceutical form comprising pellets with a matrix which influences the delivery of a modulatory substance |
| 09/07/2007 | CA2650113A1 Ankyrin-like motif-based peptides for the treatment of cancer |
| 09/07/2007 | CA2644566A1 Cancer treatments |
| 09/07/2007 | CA2644471A1 Pro-nanodispersion for the delivery of cyclosporin |
| 09/07/2007 | CA2644461A1 G-csf liquid formulation |
| 09/07/2007 | CA2644282A1 Virosome-like vesicles comprising gp41-derived antigens |
| 09/07/2007 | CA2643761A1 Nebulizer formulation |
| 09/07/2007 | CA2643569A1 Method of treating periodontitis and of reducing dentinal sensitivity |
| 09/07/2007 | CA2643492A1 Nanoparticulate carvedilol formulations |
| 09/07/2007 | CA2643330A1 Crush-resistant oxycodone tablets intended for preventing accidental misuse and unlawful diversion |
| 09/07/2007 | CA2643328A1 Crush-resistant tablets intended to prevent accidental misuse and unlawful diversion |
| 09/07/2007 | CA2643322A1 Microparticles containing biodegradable polymer and cationic polysaccharide for use in immunogenic compositions |
| 09/07/2007 | CA2643037A1 Compositions and methods for delivery of amino-functional drugs |
| 09/07/2007 | CA2643019A1 Apparatus and formulations for suprachoroidal drug delivery |
| 09/07/2007 | CA2642195A1 Fluvastatin sodium pharmaceutical compositions |
| 09/07/2007 | CA2637720A1 Antimicrobial medical devices |
| 09/07/2007 | CA2633464A1 Compositions and methods for dermal delivery of drugs |
| 09/07/2007 | CA2628964A1 Formulations of fispemifene |
| 09/07/2007 | CA2611577A1 Antibiotic kit and composition and uses thereof |
| 09/06/2007 | US20070208075 Pharmaceutical compositions |
| 09/06/2007 | US20070208060 Compounds for treating inflammatory diseases |
| 09/06/2007 | US20070207988 Topical skin care composition |
| 09/06/2007 | US20070207434 Methods and systems for concurrent tooth repositioning and substance delivery |
| 09/06/2007 | US20070207359 Crosslinked nano-inorganic particle/polymer electrolyte membrane and method for producing same, and membrane electrode assembly using same |
| 09/06/2007 | US20070207215 Medicament On The Basis Of Honey, Preparation And Use Thereof |
| 09/06/2007 | US20070207214 Oral pharmaceutical compositions with controlled release and prolonged absorption |
| 09/06/2007 | US20070207213 Injectable Microspheres From Unsaturated Functionalized Polyhydric Alcohol Esters |
| 09/06/2007 | US20070207212 Polypeptide Films and Methods |
| 09/06/2007 | US20070207211 Emulsion-based microparticles and methods for the production thereof |
| 09/06/2007 | US20070207210 Protein Microspheres Retaining Pharmacokinetic and Pharmacodynamic Properties |
| 09/06/2007 | US20070207209 Trophic factor combinations for nervous system treatment |
| 09/06/2007 | US20070207208 Compositions and Methods Using a Cardiac Glycoside |
| 09/06/2007 | US20070207207 Bioadhesive drug formulations for oral transmucosal delivery |
| 09/06/2007 | US20070207206 Chewable pain formula |
| 09/06/2007 | US20070207205 Rapidly Disintegrating Taste-Masked Tablet |
| 09/06/2007 | US20070207204 Dosage Form for Time-Varying Patterns of Drug Delivery |
| 09/06/2007 | US20070207203 Oral controlled release formulation for sedative and hypotnic agents |
| 09/06/2007 | US20070207202 Pharmaceutical formulations of a monohydrate crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol |
| 09/06/2007 | US20070207201 Liquid and Semi-Solid Pharmaceutical Formulations and Processes |
| 09/06/2007 | US20070207200 Dosage forms for administering combinations of drugs |
| 09/06/2007 | US20070207199 Appetite suppression device |
| 09/06/2007 | US20070207198 Use Of N-Acety1-D-Glucosamine In The Manufacture Of Medicaments For Anti-Tumors And Anti-Metastasis |
| 09/06/2007 | US20070207197 Composition and method for reducing symptoms of breast engorgement |
| 09/06/2007 | US20070207196 Tocopherol-modified therapeutic drug compound formulations |
| 09/06/2007 | US20070207195 Genetic Screening for Polymorphisms in Human Genes that Increase or Decrease Sensitivity to Toxic Agents |
| 09/06/2007 | US20070207194 Gene or drug delivery system |
| 09/06/2007 | US20070207193 aersols, creams, lotions |
| 09/06/2007 | US20070207192 Adhesive bioerodible transmucosal drug delivery system |
| 09/06/2007 | US20070207191 Pharmaceutical compositions and methods to achieve and maintain a targeted and stable copper status and prevent and treat copper-related central nervous system diseases |
| 09/06/2007 | US20070207190 Process for manufacturing hydrophobic polymers |
| 09/06/2007 | US20070207189 Antimicrobial medical devices |
| 09/06/2007 | US20070207188 Cocoa products and methods of treating cardiovascular conditions with sugar-free cocoa |
| 09/06/2007 | US20070207185 Compositions and methods for treating bone |
| 09/06/2007 | US20070207173 Vitamin E succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof |
| 09/06/2007 | US20070207140 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same |
| 09/06/2007 | US20070207138 S/O Type Pharmaceutical Preparation and Method for Producing the Same |
| 09/06/2007 | US20070207123 Amelioration of effects of cigarette smoke |
| 09/06/2007 | US20070207118 Surface modification of islet membranes by polymeric grafting methods |
| 09/06/2007 | US20070207092 dentifrices used for removing or inhibiting plaque and tartar, and also for treating and preventing oral and periodontal diseases |
| 09/06/2007 | US20070207091 Nebulizer Formulation |
| 09/06/2007 | US20070207090 Mucosal meningococcal vaccines |
| 09/06/2007 | US20070207089 Tamper Resistant Dosage Form Comprising an Adsorbent and an Adverse Agent |
| 09/06/2007 | US20070207088 Anti-Inflammatory Analgesic Adhesive Patch |
| 09/06/2007 | US20070206081 Ejection liquid and ejection method |
| 09/05/2007 | EP1829880A2 Derivatives of camptothecin for use in treating cancer |
| 09/05/2007 | EP1829856A2 Transfection reagents |
| 09/05/2007 | EP1829562A1 Medical tape preparation |
| 09/05/2007 | EP1829557A2 Preparation of diagnostic agents |
| 09/05/2007 | EP1829549A1 Amorphous composition |
| 09/05/2007 | EP1829547A2 Treatment of neurodegenerative disease through intracranial delivery of short interfering RNA (siRNA) |
| 09/05/2007 | EP1829546A1 Formulations containing tetracyclines for treating or preventing mucositis |
| 09/05/2007 | EP1829545A1 Prostaglandin f2 alpha derivative containing products |